Actemra IV injection 200 mg, from Chugai Pharmaceutical, contains Tocilizumab (genetically recombination). This injectable drug (YJ code: 6399421A1020) is provided as 200mg in 10mL per bottle and is used to treat various inflammatory conditions such as rheumatoid arthritis, giant cell arteritis, and systemic juvenile idiopathic arthritis.
Actemra IV injection 200 mg
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).